REVENUES (Tables)

12 Months Ended

Dec. 31, 2025

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table presents sales by operating segment disaggregated based on product category and geographic region for the years ended December 31, 2025, 2024 and 2023 (in thousands).

	2025						2024*						2023*
	United States		International		Total		United States		International		Total		United States		International		Total
Cardiovascular
Peripheral Intervention	$	341,941	$	237,899	$	579,840	$	312,667	$	220,103	$	532,770	$	280,817	$	202,448	$	483,265
Cardiac Intervention		187,355		261,559		448,914		147,961		220,990		368,951		143,715		212,935		356,650
Custom Procedural Solutions		128,570		80,763		209,333		122,156		77,877		200,033		113,839		79,878		193,717
OEM		182,716		22,239		204,955		166,160		33,830		199,990		154,232		32,696		186,928
Total		840,582		602,460		1,443,042		748,944		552,800		1,301,744		692,603		527,957		1,220,560
Endoscopy
Endoscopy Devices		68,884		3,980		72,864		51,836		2,934		54,770		34,386		2,420		36,806
Total	$	909,466	$	606,440	$	1,515,906	$	800,780	$	555,734	$	1,356,514	$	726,989	$	530,377	$	1,257,366

*Commencing January 1, 2025, we reorganized our sales teams and product categories to include revenues from the sale of our spine devices under our OEM product category. Revenue figures for 2024 and 2023 have been recast to reflect this realignment of our portfolio of spine products, representing approximately $22.6 million and $22.4 million in revenue, respectively, within the OEM product category to provide comparability between the reported periods.